Rare coding variants in the triggering receptor expressed on myeloid cells 2 (TREM2) are associated with increased risk for Alzheimer's disease (AD), but how they confer this risk remains uncertain. Here, TREM2 is linked to early-onset autosomal dominant Alzheimer disease.